GlassScriptPhysician profile
Christopher A Semder
NPI 1487858965
$49,743.34
in general payments reported to CMS, 2019-2025
28 companies · $611 in 2025
The $611 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,827 · 2020: $1,806 · 2021: $998 · 2022: $11K · 2023: $16K · 2024: $15K · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $6,455 · Food and Beverage: $4,998 · Consulting Fee: $3,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,750.00 |
| Travel and Lodging | $6,455.38 |
| Food and Beverage | $4,997.51 |
| Consulting Fee | $3,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37,281.44 | 2019-2025 | Ekosonic, Angiojet Ultra 5000a, Watchman Access System |
| Abbott Laboratories | $7,117.75 | 2019-2025 | Mitraclip, Pressurewire, Nc Trek Neo |
| Medtronic Vascular, INC. | $1,318.87 | 2019-2020 | |
| Philips North America LLC | $1,036.34 | 2019 | |
| Terumo Medical Corporation | $844.47 | 2019-2023 | Metacross Otw |
| Edwards Lifesciences Corporation | $536.38 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ekos Corporation | $285.20 | 2019 | |
| Medtronic, INC. | $244.83 | 2022-2025 | Simulus, Corevalve Evolut R |
| Pfizer INC. | $186.83 | 2021-2025 | |
| Biotronik INC. | $93.97 | 2024 | Orsiro Mission |
| Janssen Pharmaceuticals, INC | $92.73 | 2019-2023 | Xarelto |
| Inari Medical, INC. | $92.54 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $84.49 | 2019-2024 | Eliquis |
| Abiomed | $67.67 | 2023-2024 | Impella |
| Sanofi-Aventis U.S. LLC | $66.16 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $58.76 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $55.73 | 2019-2023 | Brilinta |
| Novo Nordisk INC | $44.14 | 2023 | Ozempic, Rybelsus |
| Amgen INC. | $42.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.11 | 2023-2024 | Jardiance |
| Cardiva Medical, INC. | $25.09 | 2024 | Other |
| Surmodics, INC. | $24.18 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Angiodynamics, INC. | $21.75 | 2022 | |
| Teleflex LLC | $20.17 | 2025 | |
| Bridgebio Pharma, INC. | $18.28 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $16.49 | 2024 | Arcalyst |
| Atricure, INC. | $15.48 | 2023 | |
| Cardiovascular Systems INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Semder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.